Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study (288 views visite)
Diabetes Care (ISSN: 1935-5548, 0149-5992), 2013 Sep; 36(8): 2395-2401.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 8.57, 5-year impact factor Impact factor a 5 anni: 8.462
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84885984550&partnerID=40&md5=6954dcdce4452fb9660192558219e382
Keywords Parole chiave: (3 Iodobenzyl)guanidine I 123, Aldosterone Antagonist, Angiotensin 1 Receptor Antagonist, Beta Adrenergic Receptor Blocking Agent, Bisoprolol, Calcium Channel Blocking Agent, Carvedilol, Dipeptidyl Carboxypeptidase Inhibitor, Glucose, Hemoglobin A1c, Insulin, Loop Diuretic Agent, Oral Antidiabetic Agent, Article, Clinical Assessment, Controlled Study, Diet Therapy, Disease Course, Disease Severity, Echocardiography, Female, Glucose Blood Level, Glycemic Control, Heart Failure, Heart Function, Heart Left Ventricle Ejection Fraction, Human, Major Clinical Study, Non Insulin Dependent Diabetes Mellitus, Protein Analysis, Risk Factor, Sympathetic Tone,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Advanced Biomedical Sciences, Section of Cardiology, Federico II University, Naples,Italy.
Division of Cardiology, Salvatore Maugeri Foundation, IRCCS, Institute of Telese Terme, Telese Terme (BN), Italy
Department of Translational Medical Sciences, Section of Geriatrics, Federico II University, Naples, Italy
Institute of Biostructures, Bioimages of the National Council of Research, Naples, Italy
Department of Cardiology, Fatebenefratelli Hospital, Naples, Italy
Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy
SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy
References Riferimenti:
Rengo, G., Lymperopoulos, A., Leosco, D., Koch, W.J., GRK2 as a novel gene therapy target in heart failure (2011) J Mol Cell Cardiol, 50, pp. 785-79
Lymperopoulos, A., Rengo, G., Koch, W.J., Adrenal adrenoceptors in heart failure: Fine-tuning cardiac stimulation (2007) Trends Mol Med, 13, pp. 503-511
Rengo, G., Perrone-Filardi, P., Femminella, G.D., Targeting the b-adrenergic receptor system through G-protein-coupled receptor kinase 2: A new paradigm for therapy and prognostic evaluation in heart failure: From bench to bedside (2012) Circ Heart Fail, 5, pp. 385-391
Pilotto, A., Addante, F., Franceschi, M., Multidimensional prognostic index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure (2010) Circ Heart Fail, 3, pp. 14-20
Rengo, G., Zincarelli, C., Femminella, G.D., Myocardial b(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure (2012) Br J Pharmacol, 166, pp. 2348-2361
Jacobson, A.F., Senior, R., Cerqueira, M.D., Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIREHF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study (2010) J Am Coll Cardiol, 55, pp. 2212-2221. , ADMIRE-HF Investigators
Langer, A., Freeman, M.R., Josse, R.G., Armstrong, P.W., Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia (1995) JAmCollCardiol, 25, pp. 610-618
Yufu, K., Takahashi, N., Okada, N., Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease (2012) Circ J, 76, pp. 399-404
Soläng, L., Malmberg, K., Rydén, L., Diabetes mellitus and congestive heart failure. Further knowledge needed (1999) Eur Heart J, 20, pp. 789-795
Ho, K.K., Anderson, K.M., Kannel, W.B., Grossman, W., Levy, D., Survival after the onset of congestive heart failure in Framingham Heart Study subjects (1993) Circulation, 88, pp. 107-115
Shindler, D.M., Kostis, J.B., Yusuf, S., Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry (1996) Am J Cardiol, 77, pp. 1017-1020
Gerson, M.C., Caldwell, J.H., Ananthasubramaniam, K., Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients (2011) Circ Cardiovasc Imaging, 4, pp. 87-93
Rydén, L., Standl, E., Bartnik, M., Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary (2007) Eur Heart J, 28, pp. 88-136. , Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC)
European Association for the Study of Diabetes (EASD)
Levey, A.S., Coresh, J., Balk, E., National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (2003) Ann Intern Med, 139, pp. 137-147. , National Kidney Foundation
Standards of medical care in diabetesd2012 (2012) Diabetes Care, 35 (SUPPL. 1), pp. S11-S63. , American Diabetes Association
Moghtaderi, A., Bakhshipour, A., Rashidi, H., Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy (2006) Clin Neurol Neurosurg, 108, pp. 477-481
Lang, R.M., Bierig, M., Devereux, R.B., Recommendations for chamber quantification (2006) Eur J Echocardiogr, 7, pp. 79-108. , American Society of Echocardiography's Nomenclature and Standards Committee
Task Force on Chamber Quantification
American College of Cardiology Echocardiography Committee
AmericanHeart Association
Pace, L., Perrone-Filardi, P., Mainenti, P., Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 tomography: Optimal image analysis (1998) J Nucl Med, 39, pp. 1869-1874
Flotats, A., Carrió, I., Agostini, D., Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1802-1812. , EANM Cardiovascular Committee
Ewing, D.J., Martyn, C.N., Young, R.J., Clarke, B.F., The value of cardiovascular autonomic function tests: 10 years experience in diabetes (1985) Diabetes Care, 8, pp. 491-498
Scholte, A.J., Schuijf, J.D., Delgado, V., Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: Comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1698-1705
Scherrer, U., Sartori, C., Insulin as a vascular and sympathoexcitatory hormone: Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity (1997) Circulation, 96, pp. 4104-4113
Kreiner, G., Wolzt, M., Fasching, P., Myocardial m-[123I] iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function (1995) Diabetes, 44, pp. 543-549
Scognamiglio, R., Avogaro, A., Casara, D., Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetesmellitus (1998) J Am Coll Cardiol, 31, pp. 404-412
Ziegler, D., Weise, F., Langen, K.J., Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I] metaiodobenzylguanidine scintigraphy: A 4-year prospective study in IDDM patients (1998) Diabetologia, 41, pp. 443-451
Toyama, T., Aihara, Y., Iwasaki, T., Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after betablocker or angiotensin- converting enzyme inhibitor therapy (1999) J Nucl Med, 40, pp. 217-223
Boogers, M.J., Borleffs, C.J., Henneman, M.M., Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients (2010) J Am Coll Cardiol, 55, pp. 2769-2777
Diabetes Care (ISSN: 1935-5548, 0149-5992), 2013 Sep; 36(8): 2395-2401.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 8.57, 5-year impact factor Impact factor a 5 anni: 8.462
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84885984550&partnerID=40&md5=6954dcdce4452fb9660192558219e382
Keywords Parole chiave: (3 Iodobenzyl)guanidine I 123, Aldosterone Antagonist, Angiotensin 1 Receptor Antagonist, Beta Adrenergic Receptor Blocking Agent, Bisoprolol, Calcium Channel Blocking Agent, Carvedilol, Dipeptidyl Carboxypeptidase Inhibitor, Glucose, Hemoglobin A1c, Insulin, Loop Diuretic Agent, Oral Antidiabetic Agent, Article, Clinical Assessment, Controlled Study, Diet Therapy, Disease Course, Disease Severity, Echocardiography, Female, Glucose Blood Level, Glycemic Control, Heart Failure, Heart Function, Heart Left Ventricle Ejection Fraction, Human, Major Clinical Study, Non Insulin Dependent Diabetes Mellitus, Protein Analysis, Risk Factor, Sympathetic Tone,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Advanced Biomedical Sciences, Section of Cardiology, Federico II University, Naples,Italy.
Division of Cardiology, Salvatore Maugeri Foundation, IRCCS, Institute of Telese Terme, Telese Terme (BN), Italy
Department of Translational Medical Sciences, Section of Geriatrics, Federico II University, Naples, Italy
Institute of Biostructures, Bioimages of the National Council of Research, Naples, Italy
Department of Cardiology, Fatebenefratelli Hospital, Naples, Italy
Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy
SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy
References Riferimenti:
Rengo, G., Lymperopoulos, A., Leosco, D., Koch, W.J., GRK2 as a novel gene therapy target in heart failure (2011) J Mol Cell Cardiol, 50, pp. 785-79
Lymperopoulos, A., Rengo, G., Koch, W.J., Adrenal adrenoceptors in heart failure: Fine-tuning cardiac stimulation (2007) Trends Mol Med, 13, pp. 503-511
Rengo, G., Perrone-Filardi, P., Femminella, G.D., Targeting the b-adrenergic receptor system through G-protein-coupled receptor kinase 2: A new paradigm for therapy and prognostic evaluation in heart failure: From bench to bedside (2012) Circ Heart Fail, 5, pp. 385-391
Pilotto, A., Addante, F., Franceschi, M., Multidimensional prognostic index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure (2010) Circ Heart Fail, 3, pp. 14-20
Rengo, G., Zincarelli, C., Femminella, G.D., Myocardial b(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure (2012) Br J Pharmacol, 166, pp. 2348-2361
Jacobson, A.F., Senior, R., Cerqueira, M.D., Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIREHF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study (2010) J Am Coll Cardiol, 55, pp. 2212-2221. , ADMIRE-HF Investigators
Langer, A., Freeman, M.R., Josse, R.G., Armstrong, P.W., Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia (1995) JAmCollCardiol, 25, pp. 610-618
Yufu, K., Takahashi, N., Okada, N., Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease (2012) Circ J, 76, pp. 399-404
Soläng, L., Malmberg, K., Rydén, L., Diabetes mellitus and congestive heart failure. Further knowledge needed (1999) Eur Heart J, 20, pp. 789-795
Ho, K.K., Anderson, K.M., Kannel, W.B., Grossman, W., Levy, D., Survival after the onset of congestive heart failure in Framingham Heart Study subjects (1993) Circulation, 88, pp. 107-115
Shindler, D.M., Kostis, J.B., Yusuf, S., Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry (1996) Am J Cardiol, 77, pp. 1017-1020
Gerson, M.C., Caldwell, J.H., Ananthasubramaniam, K., Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients (2011) Circ Cardiovasc Imaging, 4, pp. 87-93
Rydén, L., Standl, E., Bartnik, M., Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary (2007) Eur Heart J, 28, pp. 88-136. , Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC)
European Association for the Study of Diabetes (EASD)
Levey, A.S., Coresh, J., Balk, E., National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (2003) Ann Intern Med, 139, pp. 137-147. , National Kidney Foundation
Standards of medical care in diabetesd2012 (2012) Diabetes Care, 35 (SUPPL. 1), pp. S11-S63. , American Diabetes Association
Moghtaderi, A., Bakhshipour, A., Rashidi, H., Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy (2006) Clin Neurol Neurosurg, 108, pp. 477-481
Lang, R.M., Bierig, M., Devereux, R.B., Recommendations for chamber quantification (2006) Eur J Echocardiogr, 7, pp. 79-108. , American Society of Echocardiography's Nomenclature and Standards Committee
Task Force on Chamber Quantification
American College of Cardiology Echocardiography Committee
AmericanHeart Association
Pace, L., Perrone-Filardi, P., Mainenti, P., Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 tomography: Optimal image analysis (1998) J Nucl Med, 39, pp. 1869-1874
Flotats, A., Carrió, I., Agostini, D., Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1802-1812. , EANM Cardiovascular Committee
Ewing, D.J., Martyn, C.N., Young, R.J., Clarke, B.F., The value of cardiovascular autonomic function tests: 10 years experience in diabetes (1985) Diabetes Care, 8, pp. 491-498
Scholte, A.J., Schuijf, J.D., Delgado, V., Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: Comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1698-1705
Scherrer, U., Sartori, C., Insulin as a vascular and sympathoexcitatory hormone: Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity (1997) Circulation, 96, pp. 4104-4113
Kreiner, G., Wolzt, M., Fasching, P., Myocardial m-[123I] iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function (1995) Diabetes, 44, pp. 543-549
Scognamiglio, R., Avogaro, A., Casara, D., Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetesmellitus (1998) J Am Coll Cardiol, 31, pp. 404-412
Ziegler, D., Weise, F., Langen, K.J., Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I] metaiodobenzylguanidine scintigraphy: A 4-year prospective study in IDDM patients (1998) Diabetologia, 41, pp. 443-451
Toyama, T., Aihara, Y., Iwasaki, T., Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after betablocker or angiotensin- converting enzyme inhibitor therapy (1999) J Nucl Med, 40, pp. 217-223
Boogers, M.J., Borleffs, C.J., Henneman, M.M., Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients (2010) J Am Coll Cardiol, 55, pp. 2769-2777
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study
OBJECTIVE: Impaired parasympathetic and sympathetic nervous system activity have been demonstrated in patients with diabetes mellitus (DM) and correlated with worse prognosis. Few data are available on the effect of DM on cardiac neuropathy in heart failure (HF). The aim of the current study was to assess cardiac sympathetic activity in HF patients with and without DM.; RESEARCH DESIGN AND METHODS: Patients with severe HF (n = 75), with (n = 37) and without DM (n = 38), and 14 diabetic patients with normal cardiac function underwent (123)I meta-iodobenzylguanidine scintigraphy from which early and late heart-to-mediastinum (H/M) ratios were calculated. Clinical, echocardiographic, and biochemical data were measured.; RESULTS: DM compared with non-DM patients showed significantly lower early (1.65 ± 0.21 vs. 1.75 ± 0.21; P < 0.05) and late H/M ratios (1.46 ± 0.22 vs. 1.58 ± 0.24; P < 0.03). Early and late H/M were significantly higher in DM patients without HF (2.22 ± 0.35 and 1.99 ± 0.24, respectively) than HF patients with (P < 0.0001) and without (P < 0.0001) DM. In HF patients, an inverse correlation between early or late H/M ratio and hemoglobin A1c (HbA1c) (Pearson = -0.473, P = 0.001; Pearson = -0.382, P = 0.001, respectively) was observed. In DM, in multivariate analysis, HbA1c and ejection fraction remained significant predictors of early H/M; HbA1c remained the only significant predictor of late H/M. No correlation between early or late H/M and HbA1c was found in non-DM patients.; CONCLUSIONS: Diabetic patients with HF show lower cardiac sympathetic activity than HF patients not having DM or than DM patients with a similar degree of autonomic dysfunction not having HF. HbA1c correlated with the degree of reduction in cardiac sympathetic activity.
OBJECTIVE: Impaired parasympathetic and sympathetic nervous system activity have been demonstrated in patients with diabetes mellitus (DM) and correlated with worse prognosis. Few data are available on the effect of DM on cardiac neuropathy in heart failure (HF). The aim of the current study was to assess cardiac sympathetic activity in HF patients with and without DM.; RESEARCH DESIGN AND METHODS: Patients with severe HF (n = 75), with (n = 37) and without DM (n = 38), and 14 diabetic patients with normal cardiac function underwent (123)I meta-iodobenzylguanidine scintigraphy from which early and late heart-to-mediastinum (H/M) ratios were calculated. Clinical, echocardiographic, and biochemical data were measured.; RESULTS: DM compared with non-DM patients showed significantly lower early (1.65 ± 0.21 vs. 1.75 ± 0.21; P < 0.05) and late H/M ratios (1.46 ± 0.22 vs. 1.58 ± 0.24; P < 0.03). Early and late H/M were significantly higher in DM patients without HF (2.22 ± 0.35 and 1.99 ± 0.24, respectively) than HF patients with (P < 0.0001) and without (P < 0.0001) DM. In HF patients, an inverse correlation between early or late H/M ratio and hemoglobin A1c (HbA1c) (Pearson = -0.473, P = 0.001; Pearson = -0.382, P = 0.001, respectively) was observed. In DM, in multivariate analysis, HbA1c and ejection fraction remained significant predictors of early H/M; HbA1c remained the only significant predictor of late H/M. No correlation between early or late H/M and HbA1c was found in non-DM patients.; CONCLUSIONS: Diabetic patients with HF show lower cardiac sympathetic activity than HF patients not having DM or than DM patients with a similar degree of autonomic dysfunction not having HF. HbA1c correlated with the degree of reduction in cardiac sympathetic activity.
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study
No results. Nessun risultato. |
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study
Nappi C, Gaudieri V, Petretta M, Cuocolo A
* Noninvasive Cardiac Imaging in Obesity: Challenges and Opportunities (150 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2016; 9(9): N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Leosco D, Parisi V, Pellegrino T, Pagano G, Femminella GD, Bevilacqua A, Paolillo S, Formisano R, Ferro G, de Lucia C, Prastaro M, Filardi PP, Cuocolo A, Rengo G, Ferrara N
* Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac 123I-MIBG study (320 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42(10): 1601-1611.
Impact Factor: 5.537
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Pellegrino T, Cuocolo A
* Cardiac Neuronal Imaging With 123i-Meta-Iodobenzylguanidine In Heart Failure: Implications Of Endpoint Selection And Quantitative Analysis On Clinical Decisions (261 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2014 Sep; 41(9): 1663-1665.
Impact Factor: 5.383
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Pellegrino T, Cuocolo A
* The "gray Zone" For The Heart To Mediastinum Mibg Uptake Ratio (284 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2014; 21(5): 921-924.
Impact Factor: 2.942
Dettagli Esporta in BibTeX Esporta in EndNote
De Rosa A, Pappata S, Pellegrino T, De Leva MF, Maddaluno G, Fiumara G, Carotenuto R, Petretta M, Filla A, De Michele G, Cuocolo A
* Reduced Cardiac 123i-Metaiodobenzylguanidine Uptake In Patients With Spinocerebellar Ataxia Type 2: A Comparative Study With Parkinson'S Disease (432 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2013 Dec; 40(12): 1914-1921.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Pellegrino T, Petretta M, Paolillo S, Boemio A, Carotenuto R, Petretta MP, Di Nuzzo C, Perrone-filardi P, Cuocolo A
* Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure (369 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2013 Oct; 40(10): 1549-1557.
Impact Factor: 5.217
Dettagli Esporta in BibTeX Esporta in EndNote
Giallauria F, Acampa W, Ricci F, Gallicchio R, Xhoxhi E, Vitelli A, D'Agostino M, Lucci R, Vigorito C, Cuocolo A
* Effects of exercise training started within 2 weeks after acute myocardial infarction on myocardial perfusion and left ventricular function: A gated SPECT imaging study (339 visite)
Eur J Prev Cardiol (ISSN: 2047-4873, 2047-4881), 2012 Dec; 19(6): 1410-1419.
Impact Factor: 2.675
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Cuocolo A, Imbriaco M, Pellegrino T, Fusari M, Cuocolo R, Liuzzi R, Salvatore M
* Imaging characterization of benign and malignant pheochromocytoma or paraganglioma: comparison between MIBG uptake and MR signal intensity ratio (343 visite)
Ann Nucl Med (ISSN: 1864-6433, 0914-7187, 1864-6433electronic), 2012 Oct; 26(8): 670-675.
Impact Factor: 1.41
Dettagli Esporta in BibTeX Esporta in EndNote
Sorriento D, Santulli G, Del Giudice C, Anastasio A, Trimarco B, Iaccarino G
* Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo (386 visite)
Hypertensionhypertension (ISSN: 0194-911x), 2012; 60(1): 129-136.
Impact Factor: 6.873
Dettagli Esporta in BibTeX Esporta in EndNote
Perrone-Filardi P, Paolillo S, Dellegrottaglie S, Gargiulo P, Savarese G, Marciano C, Casaretti L, Cecere M, Musella F, Pirozzi E, Parente A, Cuocolo A
* Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal (303 visite)
Heart (ISSN: 1468-201x, 1355-6037), 2011 Nov; 97(22): 1828-1833.
Impact Factor: 4.223
Dettagli Esporta in BibTeX Esporta in EndNote
Manganelli F, Spadafora M, Varrella P, Peluso G, Sauro R, Di Lorenzo E, Rosato G, Daniele S, Cuocolo A
* Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischaemia with SPECT imaging: a randomized, placebo-controlled trial (303 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 Feb; 38(2): 245-251.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Pedone C, Di Pasquale G, Greco C, Gonzini L, Maggioni AP, Pavesi PC, Sabini A, Boccanelli A; In-Acs Outcome Investigators
* Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study (341 visite)
Acute Cardiac Care (ISSN: 1748-295x, 1748-2941), 2009; 11(4): 222-228.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferro A, Pellegrino T, Spinelli L, Acampa W, Petretta M, Cuocolo A
* Comparison Between Dobutamine Echocardiography and Single-Photon Emission Computed Tomography for Interpretive Reproducibility (244 visite)
Am J Cardiol (ISSN: 0002-9149), 2007 Oct 15; 100(8): 1239-1244.
Impact Factor: 3.603
Dettagli Esporta in BibTeX Esporta in EndNote
Maestri R, Pinna G, Accardo A, Allegrini P, Balocchi R, D'ADDIO G, Ferrario M, Menicucci D, Porta A, Sassi R
* Nonlinear indices of heart rate variability in chronic heart failure patients: Redundancy and comparative clinical value (322 visite)
J Cardiovasc Electrophysiol (ISSN: 1045-3873), 2007; 18(4): 425-433.
Impact Factor: 3.475
Dettagli Esporta in BibTeX Esporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R
* 3. 0 T perfusion MR imaging (599 visite)
Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812.
Impact Factor: 0.023
Dettagli Esporta in BibTeX Esporta in EndNote
Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Sacca L
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine (301 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1996 Dec; 81(12): 4224-4228.
Impact Factor: 4.575
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Lastoria S, Caracò C, Klain M, Varrella P, Acampa W, Muto P, Salvatore M
The role of radiolabeled somatostatin analogs in adrenal imaging (310 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 677-680.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Marotta T, Ferrara LA, Di Marino L, Mancini M, Annuzzi G, Russo O, D'Orta G, Lucarelli C, Rossi F
Factors affecting lipoprotein lipase in hypertensive patients (309 visite)
Metab Clin Exp (ISSN: 0026-0495, 1532-8600), 1995 Jun; 44(6): 712-718.
Impact Factor: 1.681
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Lastoria S, Cuocolo A, Celentano L, Salvatore M
The diagnosis of nonfunctioning pheochromocytoma the role of I-123 MIBG imaging (216 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1995 Jan; 20(1): 22-24.
Impact Factor: 0.34
Dettagli Esporta in BibTeX Esporta in EndNote
Lastoria S, Caraco C, Maurea S, Piroli C, Maurelli L, Vergara E, Klain M, Cuocolo A, Salvatore M
Evaluation of orbital involvement by neuroblastoma using radiolabeled metaiodobenzylguanidine (222 visite)
Ital J Ophthalmol (ISSN: 0394-610x), 1993; 7(3): 147-152.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
20 Records (20 escludendo Abstract e Conferenze).
Impact factor totale: 56.682 (56.682 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 65.268 (65.268 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Nappi C, Gaudieri V, Petretta M, Cuocolo A
* Noninvasive Cardiac Imaging in Obesity: Challenges and Opportunities (150 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2016; 9(9): N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Leosco D, Parisi V, Pellegrino T, Pagano G, Femminella GD, Bevilacqua A, Paolillo S, Formisano R, Ferro G, de Lucia C, Prastaro M, Filardi PP, Cuocolo A, Rengo G, Ferrara N
* Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac 123I-MIBG study (320 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42(10): 1601-1611.
Impact Factor: 5.537
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Pellegrino T, Cuocolo A
* Cardiac Neuronal Imaging With 123i-Meta-Iodobenzylguanidine In Heart Failure: Implications Of Endpoint Selection And Quantitative Analysis On Clinical Decisions (261 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2014 Sep; 41(9): 1663-1665.
Impact Factor: 5.383
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Pellegrino T, Cuocolo A
* The "gray Zone" For The Heart To Mediastinum Mibg Uptake Ratio (284 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2014; 21(5): 921-924.
Impact Factor: 2.942
Dettagli Esporta in BibTeX Esporta in EndNote
De Rosa A, Pappata S, Pellegrino T, De Leva MF, Maddaluno G, Fiumara G, Carotenuto R, Petretta M, Filla A, De Michele G, Cuocolo A
* Reduced Cardiac 123i-Metaiodobenzylguanidine Uptake In Patients With Spinocerebellar Ataxia Type 2: A Comparative Study With Parkinson'S Disease (432 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2013 Dec; 40(12): 1914-1921.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Pellegrino T, Petretta M, Paolillo S, Boemio A, Carotenuto R, Petretta MP, Di Nuzzo C, Perrone-filardi P, Cuocolo A
* Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure (369 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2013 Oct; 40(10): 1549-1557.
Impact Factor: 5.217
Dettagli Esporta in BibTeX Esporta in EndNote
Giallauria F, Acampa W, Ricci F, Gallicchio R, Xhoxhi E, Vitelli A, D'Agostino M, Lucci R, Vigorito C, Cuocolo A
* Effects of exercise training started within 2 weeks after acute myocardial infarction on myocardial perfusion and left ventricular function: A gated SPECT imaging study (339 visite)
Eur J Prev Cardiol (ISSN: 2047-4873, 2047-4881), 2012 Dec; 19(6): 1410-1419.
Impact Factor: 2.675
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Cuocolo A, Imbriaco M, Pellegrino T, Fusari M, Cuocolo R, Liuzzi R, Salvatore M
* Imaging characterization of benign and malignant pheochromocytoma or paraganglioma: comparison between MIBG uptake and MR signal intensity ratio (343 visite)
Ann Nucl Med (ISSN: 1864-6433, 0914-7187, 1864-6433electronic), 2012 Oct; 26(8): 670-675.
Impact Factor: 1.41
Dettagli Esporta in BibTeX Esporta in EndNote
Sorriento D, Santulli G, Del Giudice C, Anastasio A, Trimarco B, Iaccarino G
* Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo (386 visite)
Hypertensionhypertension (ISSN: 0194-911x), 2012; 60(1): 129-136.
Impact Factor: 6.873
Dettagli Esporta in BibTeX Esporta in EndNote
Perrone-Filardi P, Paolillo S, Dellegrottaglie S, Gargiulo P, Savarese G, Marciano C, Casaretti L, Cecere M, Musella F, Pirozzi E, Parente A, Cuocolo A
* Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal (303 visite)
Heart (ISSN: 1468-201x, 1355-6037), 2011 Nov; 97(22): 1828-1833.
Impact Factor: 4.223
Dettagli Esporta in BibTeX Esporta in EndNote
Manganelli F, Spadafora M, Varrella P, Peluso G, Sauro R, Di Lorenzo E, Rosato G, Daniele S, Cuocolo A
* Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischaemia with SPECT imaging: a randomized, placebo-controlled trial (303 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 Feb; 38(2): 245-251.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Pedone C, Di Pasquale G, Greco C, Gonzini L, Maggioni AP, Pavesi PC, Sabini A, Boccanelli A; In-Acs Outcome Investigators
* Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study (341 visite)
Acute Cardiac Care (ISSN: 1748-295x, 1748-2941), 2009; 11(4): 222-228.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferro A, Pellegrino T, Spinelli L, Acampa W, Petretta M, Cuocolo A
* Comparison Between Dobutamine Echocardiography and Single-Photon Emission Computed Tomography for Interpretive Reproducibility (244 visite)
Am J Cardiol (ISSN: 0002-9149), 2007 Oct 15; 100(8): 1239-1244.
Impact Factor: 3.603
Dettagli Esporta in BibTeX Esporta in EndNote
Maestri R, Pinna G, Accardo A, Allegrini P, Balocchi R, D'ADDIO G, Ferrario M, Menicucci D, Porta A, Sassi R
* Nonlinear indices of heart rate variability in chronic heart failure patients: Redundancy and comparative clinical value (322 visite)
J Cardiovasc Electrophysiol (ISSN: 1045-3873), 2007; 18(4): 425-433.
Impact Factor: 3.475
Dettagli Esporta in BibTeX Esporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R
* 3. 0 T perfusion MR imaging (599 visite)
Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812.
Impact Factor: 0.023
Dettagli Esporta in BibTeX Esporta in EndNote
Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Sacca L
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine (301 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1996 Dec; 81(12): 4224-4228.
Impact Factor: 4.575
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Lastoria S, Caracò C, Klain M, Varrella P, Acampa W, Muto P, Salvatore M
The role of radiolabeled somatostatin analogs in adrenal imaging (310 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 677-680.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Marotta T, Ferrara LA, Di Marino L, Mancini M, Annuzzi G, Russo O, D'Orta G, Lucarelli C, Rossi F
Factors affecting lipoprotein lipase in hypertensive patients (309 visite)
Metab Clin Exp (ISSN: 0026-0495, 1532-8600), 1995 Jun; 44(6): 712-718.
Impact Factor: 1.681
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Lastoria S, Cuocolo A, Celentano L, Salvatore M
The diagnosis of nonfunctioning pheochromocytoma the role of I-123 MIBG imaging (216 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1995 Jan; 20(1): 22-24.
Impact Factor: 0.34
Dettagli Esporta in BibTeX Esporta in EndNote
Lastoria S, Caraco C, Maurea S, Piroli C, Maurelli L, Vergara E, Klain M, Cuocolo A, Salvatore M
Evaluation of orbital involvement by neuroblastoma using radiolabeled metaiodobenzylguanidine (222 visite)
Ital J Ophthalmol (ISSN: 0394-610x), 1993; 7(3): 147-152.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
20 Records (20 escludendo Abstract e Conferenze).
Impact factor totale: 56.682 (56.682 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 65.268 (65.268 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:53
288 views visite. Last view on Ultima visita in data Tuesday 11 May 2021, 15:13:53
ibb.cnr.it